Skip to main content
. 2022 Apr 29;4(5):e0682. doi: 10.1097/CCE.0000000000000682

TABLE 1.

Demographic Data

Variable All Patients Survival 12 mo Death 12 mo p
n 1,379 1,318 61
Age, yr, median (IQR) 69 (62–76) 69 (62–76) 71 (66–78) 0.076
Male sex, n (%) 902 (65.4) 860 (65.3) 42 (68.9) 0.679
Hypertension, n (%) 1,117 (81) 1,069 (81.1) 48 (78.7) 0.618
Diabetes mellitus, n (%) 430 (31.2) 413 (31.3) 17 (27.9) 0.672
Dyslipidemia, n (%) 840 (60.9) 802 (60.9) 38 (62.3) 0.894
Chronic kidney disease, n (%) 356 (25.8) 323 (24.5) 33 (54) < 0.0001
Peripheral vascular disease, n (%) 98 (7.1) 95 (7.2) 3 (8.2) 0.797
Cerebrovascular disease, n (%) 96 (7) 88 (6.7) 8 (13.1) 0.067
Chronic lung disease, n (%) 158 (11.5) 147 (11.2) 11 (18) 0.102
Ischemic cardiopathy, n (%) 384 (27.8) 371 (28.1) 13 (21.3) 0.306
Previous cardiac surgery, n (%) 26 (1.9) 26 (2) 0 (0) 0.626
Preserved LV function, n (%) 1,107 (80.3) 1,062 (80.6) 45 (73.8) 0.19
Moderate LV function (31–50%), n (%) 132 (9.6) 127 (9.6) 5 (8.2) > 0.999
Poor LV function (21–30%), n (%) 100 (7.2) 93 (7) 7 (11.5) 0.202
Very poor LV function (< 20%), n (%) 40 (2.9) 36 (2.7) 4 (6.6) 0.097
Elective 1,264 (91.7) 1,218 (92.4) 46 (75.4) < 0.0001
Urgent 69 (5) 62 (4.7) 7 (11.5) 0.029
Emergent 46 (3.3) 38 (2.9) 8 (13.1) 0.0006
European System for Cardiac Operative Risk Evaluation II (IQR) 1.64 (1.11–3.07) 1.62 (1.08–2.98) 3.03 (1.65–5.89) < 0.0001
Isolated CABG 387 (28.1) 377 (28.6) 10 (16.4) 0.041
Single non-CABG 650 (47.1) 622 (47.2) 28 (45.9) 0.896
Two procedures 283 (20.5) 266 (20.2) 17 (27.9) 0.147
Three procedures 59 (4.3) 53 (4) 6 (9.8) 0.042
Thoracic aorta surgery 124 (9) 116 (8.8) 8 (13.1) 0.249
Cardiopulmonary bypass time, min (IQR) 63 (43.8–88) 62 (43–86) 85 (62–104) 0.0009
Cross-clamp time, min (IQR) 50 (34–68.3) 50 (34–67) 58 (44–77) 0.018

CABG = coronary artery bypass graft, IQR = interquartile range, LV = left ventricular.